Previous studies have shown that TNF-α blockade in RA diminishes local inflammation in the joints by decreasing synovial cell infiltration as well as the expression of adhesion molecules, chemokines and cytokines, which coincides with reduction in acute phase reactants, such as CRP and IL-6 [31,32]. Here, CRP is linked to rheumatoid arthritis.